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Objective: Gastroesophageal reflux is thought to be a risk factor for laryngotracheal stenosis. Bile acids are a component
of gastric refluxate and have previously been implicated in the development of fibrosis in other airway subsites. There is clear
evidence that bile acids reflux into the upper airway. We therefore investigated the potential role of bile acids in the patho-
physiology of laryngotracheal fibrosis and stenosis, specifically investigating the highly conserved process of epithelial–mesen-
chymal transition (EMT).
Study Design: Translational research study.
Methods: Human primary tracheal epithelial cells (PTECs) were challenged with the four most common digestive bile
acids (cholic, chenodeoxycholic, deoxycholic, and lithocholic). EMT markers transforming growth factor (TGF)-b1, Matrix met-
alloproteinase (MMP)-9, and procollagen proteins were measured in the supernatant at 48 hours via enzyme-linked immuno-
sorbent assay. Real-time polymerase chain reaction was also used to measure E-cadherin and fibronectin expression.
Results: Significantly greater concentrations of TGF-b1 and MMP-9 were measured in the culture supernatants of cells
treated with each bile acid at 10 mmol/L. Lithocholic acid and deoxycholic acid induced significantly increased expression of
procollagen protein. Upregulation of fibronectin and downregulation of E-cadherin were observed with all bile acids, except
for deoxycholic acid.
Conclusion: This is the first proof of principle demonstration that physiologically relevant bile acid challenge induces
EMT mechanisms in PTECs. This implies a potential role for bile acids in laryngotracheal scarring and airway remodeling of
potential translational significance in laryngotracheal stenosis.
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INTRODUCTION
Acquired laryngotracheal stenosis (LTS) most com-
monly occurs as a result of prolonged tracheal intuba-
tion.1 The subsequent airway narrowing can result in
potentially life-threatening airway obstruction.1 Only a
small proportion of patients who undergo long-term
intubation develop LTS, and LTS can occur in patients
without any history of intubation; therefore, other mech-
anisms of injury have been proposed.1–3
The relationship between gastroesophageal reflux
(GER) and LTS is not fully understood; however, a num-
ber of studies have demonstrated an association.4–6
There is clear evidence that gastroduodenal contents are
refluxed far beyond the esophagus during extraesopha-
geal or laryngopharyngeal reflux (LPR).7 The three prin-
ciple components of gastric refluxate are gastric acid,
pepsin, and bile acids. Evidence of all three components
has been found in airway bronchoalveolar lavage sam-
ples8–10; however, bile acids in particular are increas-
ingly identified as critical to propagation of disease in
sites distant from the stomach.11,12
LTS is thought to involve an abnormal response of
epithelial cells to injury, resulting in sustained inflam-
mation and fibrosis. This is defined by fibroblast prolifer-
ation, collagen deposition, and ultimately the formation
of scar tissue in the airway.13,14 Activated fibroblasts are
the principle mediators of tissue remodeling, and one of
the key sources of fibroblast accumulation is thought to
be epithelial–mesenchymal transition (EMT).15 In EMT,
epithelial cells transform to activated fibroblasts, and
transforming growth factor (TGF)-b1 is a recognized
master switch for this process.16 EMT is demonstrated
by downregulation of epithelial markers such as
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E-cadherin and increased expression of mesenchymal
markers including fibronectin, matrix metalloproteinase
(MMP)-9, and procollagen from epithelial cells.17 We
therefore investigated the mechanisms of EMT in
response to an in vitro model of biliary reflux on human
primary airway epithelial cells. We hypothesized that
laryngotracheal epithelial cells undergo EMT in
response to bile acid stimulation, representing a poten-
tial mechanism of fibrosis and ultimately LTS.
MATERIALS AND METHODS
Cell Culture
The appropriate ethical committee and hospital institu-
tions granted approval for the study. Human primary tracheal
epithelial cells (PTECs) from the upper airways of healthy vol-
unteers were collected via a sheathed cytology brush. The cells
were pelleted and then cultured on collagen (0.03mg/mL)-
coated flasks in bronchial epithelial growth medium (Lonza,
Allendale, NJ), supplemented with penicillin/streptomycin 100
U/mL (Sigma-Aldrich, St. Louis, MO), incubated at 37 8C in a
5% CO2 incubator. Medium was changed every 2 to 3 days.
Upon near confluence, cells were trypsinized (Sigma-Aldrich),
diluted in an equal volume of medium containing 10% fetal calf
serum, centrifuged at 200g for 7 minutes, and seeded in a new
container
Bile Acid Preparation and Challenge
The four major bile acids in the human digestive tract are
cholic acid (CA), chenodeoxycholic acid (CDCA), deoxycholic acid
(DCA), and lithocholic acid (LCA). Bile acids (Sigma-Aldrich) were
diluted in serum-free medium to achieve the concentrations for
each experiment. Bile acid solutions were incubated with cells for
48 hours at 37 8C in a 5% CO2 incubator. Maximal nonlethal con-
centration of bile acids to be used for stimulation were determined
via a cell viability assay using the CellTiter-Blue viability assay
(Promega Corp. Madison, WI). Cell viability was confirmed
at>90% in each experimental condition.
Enzyme-Linked Immunosorbent Assays
Cell supernatant was collected and stored at 220 8C. The
supernatant is the media in which the cells were growing and
is a standard measurement used in cell culture studies to assay
biomarkers secreted by the cells. Human TGF-b1, Human
MMP-9, and Pro-Collagen DuoSet enzyme-linked immunosor-
bent assay (ELISA) kits (R&D Systems, Minneapolis, MN) were
used according to the manufacturer’s instructions.
RNA Processing and Polymerase Chain
Reaction
Human RNA was isolated from cultured cells, as directed by
the RNeasy Midi Kit (Qiagen, Hilden, Germany), and the concen-
trations and quality were assessed by ultraviolet spectroscopy.
RNA was reverse-transcribed using the Tetro cDNA synthesis kit
(Bioline, London, UK) in accordance with the manufacturer’s
guidelines. TaqMan primer-probes (SensiFAST Probe Hi-ROX Kit,
Bioline) were used to determine the expression of genes of inter-
est, E-cadherin (Hs01023894-m1-CDH1) and fibronectin
(Hs00365052m-1FN1). The expression of each test gene was nor-
malized against expression of a housekeeping gene, hypoxanthine-
guanine phosphoribosyl transferase-1 (HPRT1) (Hs02800695-m1).
Statistical Analysis
Data from three technical and three biological replicates
were analysed using GraphPad Prism v6 (GraphPad Software,
Inc., La Jolla CA). All data are represented as mean6 standard
error of the mean (SEM), and n expressed the number of
repeat experiments that were performed. For experimental
comparison of 3 or more groups, repeated measures one-way
analysis of variance was used, followed by Bonferroni post-hoc
test, which compares all pairs of groups. In line with conven-
tion, P values of0.05 were considered significant. In this
study, * refers to P<0.05; ** refers to P<0.01; and *** refers
to P<0.001.
RESULTS
Effect of Bile Acids on an Epithelial Marker E-
Cadherin
After 48-hour bile acid stimulation, real-time poly-
merase chain reaction (RT-PCR) analysis of E-cadherin
expression in PTECs demonstrated a significant
(P< 0.001) decrease at 1 mmol/L and 10 mmol/L of CA and
CDCA, in addition at 10mmol/L of LCA. CA at concen-
tration 1 and 10 mmol/L induced threefold decreases,
showing no concentration-dependency effect. CDCA at 1
and 10mmol/L caused a twofold decrease, showing no
concentration-dependency effect. LCA at 10 mmol/L
caused a twofold decrease in E-cadherin. No significant
decrease was observed in cells stimulated with 1lmol/L
LCA. Interestingly, there was significant increase at
both concentrations of DCA, showing a negative concen-
tration dependency effect (Fig. 1A).
Effect of Bile Acids on Mesenchymal Marker
Fibronectin
Fibronectin expression was found to be significantly
increased in PTEC, measured via RT-PCR. It was found
that CA at 1 and 10mmol/L caused a threefold increase,
and 10lmol/L LCA caused a threefold increase in fibro-
nectin, showing no concentration dependency effect.
CDCA at 1 mmol/L caused a threefold increase, and
CDCA at 10mmol/L caused a fourfold increase in fibro-
nectin, showing no clear concentration dependency
effect. DCA at 1 mmol/L caused a threefold increase in
fibronectin. No significant increase was observed in cells
stimulated with DCA at 10 mmol/L and LCA at 1 mmol/L
(Fig. 2B).
Effect of Bile Acids on TGF-b1, MMP-9, and
Procollagen Expression in Cell Supernatant
We demonstrated a significant increase in expres-
sion of TGF-b1 in the cell supernatant of PTEC after 48
hours of exposure to all bile acids at 1 mmol/L and
10mmol/L (Fig. 2A). Similarly, all bile acids at concentra-
tions of 1 mmol/L and 10 mmol/L (except CA at 1 mmol/L)
showed a significant increase in MMP-9 expression in
the cell supernatant (Fig. 2B). Procollagen was signifi-
cantly increased after LA challenge at 1 mmol/L and
10mmol/L and at 10 mmol/L with DCA challenge. Produc-
tion of procollagen after stimulation with DCA at 1lmol/
L, CA at 1 and 10mmol/L, and CDCA 1 and 10 mmol/L
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did not increase significantly. Moreover, exposure to
5ng/mL TGF-b1 caused a significant increase in MMP-9
and procollagen protein production (Fig. 2C).
DISCUSSION
We have demonstrated a potential role of bile acids
in the development of EMT, a process that is implicated
in airway fibrosis and subsequently in laryngotracheal
stenosis (LTS). We utilized human primary tracheal epi-
thelial cells (PTECs), challenged with levels of bile acids
in the range previously shown to be physiologically rele-
vant by Sereg-Bahar et al. in previous work, which has
shown that the mean levels of bile acids in patients with
LPR were 2.163.0mmol/L.10 To our knowledge, this is
the first study to investigate a possible role of bile acids
in upper airway fibrosis using primary cells. The poten-
tial relationship between GER disease and LTS has been
suggested by several observational studies.4–6 Bile acids
have also been implicated in EMT in the lower airway.11
The identification of bile acids as a potential factor
in LTS is important because this may allow novel thera-
peutics for the prevention or treatment of LTS to be uti-
lized in high-risk patients, such as people undergoing
long-term intubation. Those undergoing long-term intuba-
tion may already be on acid suppression therapy, such as
proton pump inhibitors. However, these agents may not
alter the activity or concentration of bile acids in reflux-
ate. Bile acids have a broad range of activity in nonacidic
environments, making their involvement in lung patho-
physiology biologically plausible.18 Barrier agents such as
alginates or other novel targeted therapies might there-
fore be needed to fully protect from biliary reflux.
We have demonstrated that all four bile acids com-
monly identified in human refluxate have a role to some
degree in airway EMT pathways. At each stage in the
EMT process, we demonstrated characteristic changes
with bile acid challenges on primary tracheal epithelial
cells. Increased expression of TGF-b1 is considered the
master switch of EMT. E-cadherin is critical in epithelial
polarity maintenance and therefore the development of
tight junctions. Acquisition of the mesenchymal pheno-
type is characterized by an increase in the mesenchymal
marker, fibronectin, which plays a role in tissue repair,
cell migration and adhesion, and a number of other pro-
cesses.19 EMT is also characterized by expression of
MMP-9, a type IV collagenase and part of the EMT prote-
ome that degrades basement membranes. Collagen type
IV forms the reticular basement membrane upon which
epithelial cells lie. By disrupting the basement membrane
of airway epithelium, MMPs can cause inflammation,
translocation, and further EMT,17 as marked by procolla-
gen production from challenged epithelial cells.
Our findings show that E-cadherin gene expression
levels did not decrease after stimulation with 1lmol/L
LCA, which may represent a threshold effect. The con-
centration of BAs that reach the upper airway may be at
high concentration, however. It has been shown that the
mean levels of bile acids in patients with LPR were
2.16 3.0mmol/L,10 and that levels of total bile acids
of> 10 mmol/L were measured in individual patients.10
The results of this study indicate that RT-PCR anal-
ysis of E-cadherin expression revealed a significant
increase at both concentrations of DCA, showing a nega-
tive concentration-dependency effect. We think this is of
Fig. 1. (A) E-cadherin mRNA expression following bile acid and
TGF-b1 treatment. Confluent tracheal epithelial cells from the sub-
glottic area were cultured for 48 hours under various conditions as
follows: medium, medium containing 5ng/mL of TGF-b1 or 1 and
10lmol/l of LCA, DCA, CA, and CDCA. HPRT1 mRNA was used to
normalize E-cadherin RNA mRNA levels, which were presented as
mean6SEM (n5 3). These results are from 3 similar experiments.
(B) Fibronectin mRNA expression following BA and TGF-b1 treat-
ment. Confluent tracheal epithelial cells from the subglottic area
were cultured for 48 hours under various conditions as follows:
medium; medium containing 5ng/mL of TGF-b1 or 1 and 10lmol/L
of LCA, DCA, CA, and CDCA. HPRT1 mRNA was used to normalize
fibronectin mRNA levels, which were presented as mean6SEM
(n5 3). These results are representative from 3 similar experiments.
**5P<0.01, ***5P<0.001, ****5P<0.0001 compared to control,
ANOVA.
ANOVA5 analysis of variance; CA5 cholic acid; CDCA5 cheno-
deoxycholic acid; DCA5deoxycholic acid; LCA5 lithocholic acid;
SEM5 standard error of the mean; TGF5 transforming growth factor.
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potential significance. One speculation we could make is
that the challenge of epithelial cells by some individual
bile acids may augment epithelial marker expression.
The results of this study indicate that fibronectin
gene expression levels did not increase after stimulation
with 10lmol/L DCA, which contrasted with a significant
upregulation with 1 lmol/L DCA. Of note, it has been
shown that bile acids inhibit intracellular function as
they accumulate. This does not kill the cell but reduces
the rate of all cellular processes such as protein synthe-
sis.20 Overall, our data makes a case for further studies
of an underresearched area and for the investigation of
individual bile acids because our work shows clear dif-
ferences in the response of PTECs to the different bile
acids that we evaluated.
This is also illustrated by our finding of procollagen
protein after stimulation of human subglottic cells with
DCA at 1 lmol/L and CA at 1 and 10m lmol/L, contrast-
ing with our data for CDCA 1 and 10mmol/L, in which
procollagen did not increase significantly.
Our findings are further supported by Karagianni-
dis et al.,21 who confirmed increased TGF-b1, a key
EMT marker, in benign tracheal stenosis biopsies. Fur-
ther studies have demonstrated links between aspiration
of gastric refluxate and progression of a number of lower
airway fibrotic diseases, including cystic fibrosis, lung
transplant rejection, chronic obstructive pulmonary dis-
ease, and pulmonary fibrosis.12,18 Furthermore, EMT is
strongly implicated in laryngotracheal malignancies, and
further investigation of the role of bile acids in these
cancers is needed.22
Cells were also stimulated with 5ng/mL TGF-b1 as
a positive control in our study. This followed preliminary
work in which we established that 5ng/mL was an opti-
mum concentration of TGF-b1 to stimulate primary
PTECs and cell lines. Published studies also suggest
that 5ng/mL of TGF-b1 induces morphological changes
in immortalized cell lines.23–25 The mechanism by which
TGF-b1 upregulates MMP-9 and procollagen has not
been fully established. The signal-inducing flow initiated
by the binding of TGF-b1 to its receptors may be directly
responsible.26,27 Moreover, TGF-b1 may upregulate some
mediators that regulate MMP-9 (e.g., nitric oxide) that
can increase MMP-9 activity.28
This is an in vitro study, and has obvious limita-
tions for direct extrapolation into the in vivo environ-
ment. There is currently no clear evidence quantifying
the concentrations of individual bile acids in the laryngo-
pharynx or trachea during or after reflux events. We
Fig. 2. (A) ELISA of TGFb1 levels in culture medium produced by
tracheal epithelial cells from the subglottic area, cells treated with
LCA, DCA, CA, and CDCA. Statistical analysis was conducted by
one-way ANOVA (n56). (B) ELISA of MMP-9 production from tra-
cheal epithelial cells from the subglottic area cell line treated with
LCA, DCA, CA, and CDCA. Statistical analysis was conducted by
one-way ANOVA (n5 6). (C) ELISA of procollagen production from
tracheal epithelial cells from the subglottic area treated with LCA,
DCA, CA, and CDCA. Statistical analysis was conducted by one-
way ANOVA (n5 6).
Bars represent mean (6SEM) values of each group.
*P<0.05, **P<0.01, ***P<0.001.
ANOVA5analysis of variance; CA5 cholic acid; CDCA5
chenodeoxycholic acid; DCA5deoxycholic acid; ELISA5 enzyme-
linked immunosorbent assays; LCA5 lithocholic acid; MMP-
95matrix metallopeptidase 9; SEM5 standard error of the
mean; TGF5 transforming growth factor.
Laryngoscope 00: Month 2018 Aldhahrani et al.: Bile Acids and Laryngotracheal Stenosis
4
used concentrations that were maximally stimulating
without any significant loss of cell viability, and that
have previously been demonstrated to be physiologically
relevant in LPR patients in whom total bile acid levels
of up to 10 umol/L were measured.
Further investigations of the dose response relation-
ship over a broader range of concentrations would thus
be of interest in future studies, combined with measure-
ments of individual bile acids in the upper airway.
CONCLUSION
We have demonstrated that bile acids can induce
markers of EMT in PTECs, a process that may underlie
the development of LTS because bile acids come in con-
tact with this region of the airway in reflux disease.
This in vitro study suggests a potential causative or syn-
ergistic role of bile acids in the development of acquired
LTS. Crucially, biliary reflux is a highly treatable target
in those at high risk of development of LTS, indicating a
potential translational significance of our findings.
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